Drug Coverage Lookup

See how a prescription drug is placed across Medicare Part D plan formularies — tier, prior authorization, step therapy, and quantity limits, counted per unique plan.

LYNKUET (Elinzanetant)

On Part D plan formularies — with restrictions

Found on the formularies of 13 of 5499 Medicare Part D plans in this dataset · Tiers 1–4 · prior authorization on 6 plans (46%) · quantity limits on 6 (46%), counting a plan when at least one form/strength carries the flag.

This is dataset-wide formulary placement (data current through 2026-08-31) — check your specific plan for its current coverage and restrictions.

Found on the formularies of 13 of 5499 Medicare Part D plans in this dataset, but prior authorization appears on 6 of those 13 plans (for at least one form/strength). Check your specific plan for its current rules, and learn what your prescriber needs to submit.
How prior authorization works →
PlanTierPrior AuthStep TherapyQty Limit
Mass General Brigham SCO (HMO D-SNP) (H0777-001) (MA) Tier 1 Yes No 60 per 30 days
Mass General Brigham One Care (HMO D-SNP) (H1611-001) (MA) Tier 1 Yes No 60 per 30 days
Providence Medicare Extra Part B Only + Rx (HMO) (H9047-013) (OR) Tier 4 No No None
Providence Medicare Prime + Rx (HMO) (H9047-037) (OR) Tier 4 No No None
Providence Medicare Dual Plus (HMO D-SNP) (H9047-043) (OR) Tier 4 No No None
Providence Medicare Timber + Rx (HMO) (H9047-054) (OR,WA) Tier 4 No No None
Providence Medicare Pine + Rx (HMO) (H9047-063) (WA) Tier 4 No No None
Providence Medicare Extra + Rx (HMO) (H9047-064) (OR,WA) Tier 4 No No None
Providence Medicare Sycamore + Rx (HMO) (H9047-066) (CA) Tier 4 No No None
Mass General Brigham Advantage (PPO) (H9485-001) (MA) Tier 4 Yes No 60 per 30 days
Mass General Brigham Advantage Secure (HMO-POS) (H6847-001) (MA) Tier 4 Yes No 60 per 30 days
Mass General Brigham Advantage Premier (PPO) (H9485-002) (MA) Tier 4 Yes No 60 per 30 days
Mass General Brigham Advantage Signature (PPO) (H9485-003) (MA) Tier 4 Yes No 60 per 30 days

One row per plan; a Yes means the flag applies to at least one form/strength on that plan.

Acquisition cost (NADAC): $9.98057/unit — price effective 08/19/2026

For benefits professionals
Plan sponsors and advisors: formulary-placement and utilization analysis across plans.
For benefits teams: plan formulary analysis →

Source: CMS Monthly Prescription Drug Plan Formulary and Pharmacy Network Information — data current through 2026-08-31 (CMS release 2026-08-26, refreshed monthly) · NADAC price effective 08/19/2026 (per-NDC last change, not a data-staleness date). Dataset-wide plan-year formulary placement, not a guarantee of your individual benefit — confirm with your plan or pharmacist.

Data: CMS Monthly Part D formulary files · FDA/RxNorm drug identity · CMS NADAC pricing — CMS Part D formulary data current through 2026-08-31 · source

Machine access — this tool is available as structured data for AI assistants and agents:
GET https://insurewith.ai/tools/drug-coverage/data.json?drug=elinzanetant
InsureWith Assistant
Hi! I can help you understand drug coverage, formulary tiers, prior authorization, and more. What would you like to know?